Unregistered

In the June 13 Time magazine (Dr. Oz is on the cover) "MD Anderson and Massachusetts General Hospitals are doing genomic analysis which uses sequencing technology to guide treatment of patients in clinical trials. Even with out the full genome map of certain cancers, clinicians are using known mutations linked to cancer to dictate which drugs patients receive. In MD Anderson's program, all lung cancer patients are offered the chance to join a trial in which their tumors are genetically analyzed for some well known genetic defects thought to play a role in cancer. About 12% of lung cancers for example, show mutations in a gene that makes a protein critical for cell growth. Patients with this aberration can enroll in trials in which FDA approved drugs targeting that mutation are being tested as a first line therapy, instead of chemotherapy, for treating their disease, giving them a head start in gaining any benefits the drugs might porvide. (At the moment, these drugs are approved only for patients with advanced cancer for whom other therapies have failed.)"

This is just a snipit of the article, I don't know anything about this, it is still something worth checking out.

Gods blessings